[1]
“Economic and clinical impact of alternative disease management strategies for secondary prevention in diabetes type 2 in the Swiss setting”, Swiss Med Wkly, vol. 131, no. 2122, pp. 303–310, Jun. 2001, doi: 10.4414/smw.2001.09716.